The Hardest Job in Biopharma? The Vice President of Market Access ...

Beyond technology, regulations weigh heavily on the minds of pharma executives. Four out of 10 leaders believe regulatory ...

The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade ...

Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus™ Access and Patient Support, outlines the recent shift in the patient services industry towards a hybrid hub model for ...

Lilly announced several changes to its executive leadership team. 1 These changes are mostly related to the company’s ...

Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

In an effort to combat the state’s shortage of primary care physicians, Blue Cross Blue Shield of Massachusetts is offering ...

Founder and CEO of Alume Biosciences, Quyen Nguyen, MD, PhD, discusses nerve regeneration, nerve visualization and the reason behind what she does at Alume Biosciences.

With this is mind, Abbott announced a new program that combines one of the most popular sports in the world with education ...

Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and ...

Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.